1 |
Thiel, V., Ivanov, K. A., Putics, A., Hertzig, T., Schelle, B., Bayer, S., Weissbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., Gorbalenya, A. E. and Ziebuhr, J. 2003. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84, 2305-2315.
DOI
ScienceOn
|
2 |
Wu, C. Y., Jan, J. T., Ma, S. H., Kuo, C. J., Juan, H. F., Cheng, Y. S., Hsu, H. H., Huang, H. C., Wu, D., Brik, A., Liang, F. S., Liu, R. S., Fang, J. M., Chen, S. T., Liang, P. H. and Wong, C. H. 2004. Small molecules targeting severe acute respiratory sundrome human coronavirus. Proc. Natl. Acad. Sci. USA 101, 10012-10017.
DOI
ScienceOn
|
3 |
Xiong, B., Gui, C. S., Xu, X. Y., Luo, C., Chen, J., Luo, H. B., Chen, L. L., Li, G. W., Sun, T., Yu, C. Y., Yue, L. D., Duan, W. H., Shen, J. K., Qin, L., Shi, T. L., Li, Y. X., Chen, K. X., Luo, X. M., Shen, X., Shen, J. H. and Jiang, H. L. 2003. A 3D model of SARS-CoV 3CL proteinase and 54 inhibitors design by virtual screening. Acta Pharmacol. Sin. 24, 497-504.
|
4 |
Zhang, X. W., Yap, Y. L. and Altmeyer, R. M. 2005. Generation of predictive pharmacophore model for SARS-coronavirus main proteinase. Eur. J. Med. Chem. 40, 57-62.
DOI
ScienceOn
|
5 |
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., Rollin, P. E., Dowell, S. F., Ling, A. E., Humphrey, C. D., Shieh, W. J., Guarner, J., Paddock, C. D., Rota, P., Fields, B., DeRisi, J., Yang, J. Y., Cox, N., Hughes, J. M., LeDuc, J. W., Bellini, W. J. and Anderson L. J.; SARS Working Group. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953-1966.
DOI
ScienceOn
|
6 |
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, L. F., Lui, S. F., Szeto, C. C., Chung, S. and Sung, J. J. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1986-1994.
DOI
ScienceOn
|
7 |
Liu, Z., Huang, C., Fan, K., Wei, P., Chen, H., Liu, S., Pei, J., Shi, L., Li, B., Yang, K., Liu, Y. and Lai, L. 2005. Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase. J. Chem. Inf. Model. 45, 10-17.
DOI
ScienceOn
|
8 |
Marra, M. A., Jones, S. J., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S., et al. 2003. The genome sequence of the SARS-associated coronavirus. Science 300, 1399-1404.
DOI
|
9 |
Myint, S. H. 1995. Human coronavirus infections, pp. 389-401, In Siddell S. G. (eds.), The coronaviridae. Plenum Press.
|
10 |
Peiris, J. S., Yuen, K. Y., Osterhaus, A. D. and Stöhr, K. 2003. The severe acute respiratory syndrome. N. Engl. J. Med. 349, 2431-2441.
DOI
ScienceOn
|
11 |
Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H. R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A., Berger, A., Burguiere, A. M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J. C., Müller, S., Rickerts, V., Stürmer, M., Vieth, S., Klenk, H. D., Osterhaus, A. D., Schmitz, H. and Doerr, H. W. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967-1976.
DOI
ScienceOn
|
12 |
Ruan, Y. J., Wei, C. L., Ee, A. L., Vega, V. B., Thoreau, H., Su, S. T., Chia, J. M., Ng, P., Chiu, K. P., Lim, L., Zhang, T., Peng, C. K., Lin, E. O., Lee, N. M., Yee, S. L., Ng, L. F., Chee, R. E., Stanton, L. W., Long, P. M. and Liu, E. T. 2003. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361, 1779-1785.
DOI
ScienceOn
|
13 |
Seki, E., Matsuda, N., Yokoyama, S. and Kigawa, T. 2008. Cell-free protein synthesis system from Escherichia coli cells cultured at decreased temperatures improves productivity by decreasing DNA template degradation. Anal. Biochem. 377, 156-161.
DOI
ScienceOn
|
14 |
Thiel, V., Herold, J., Schelle, B. and Siddell, S. G. 2001. Viral replicase gene products suffice for coronavirus discontinuous transcription. J. Virol. 75, 6676-6681.
DOI
ScienceOn
|
15 |
Fan, K., Wei, P., Feng, Q., Chen, S., Huang, C., Ma, L., Lai, B., Pei, J., Liu, Y., Chen, J. and Lai, L. 2004. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J. Biol. Chem. 279, 1637-1642.
DOI
|
16 |
Fouchier, R. A., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, G. J., van den Hoogen, B. G., Peiris, M., Lim, W., Stohr, K. and Osterhaus, A. D. 2003. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423, 240.
DOI
ScienceOn
|
17 |
Kigawa, T., Yabuki, T., Yoshida, Y., Tsutsui, M., Ito, Y., Shibata, T. and Yokoyama, S. 1999. Cell-free production and stable-isotope labeling of milligram quantities of protein. FEBS Lett. 442, 15-19.
DOI
ScienceOn
|
18 |
Kao, R. Y., Tsui, W. H., Lee, T. S., Tanner, J. A., Watt, R. M., Huang, J. D., Hu, L., Chen, G., Chen, Z., Zhang, L., He, T., Chan, K. H., Tse, H., To, A. P., Ng, L. W., Wong, B. C., Tsoi, H. W., Yang, D., Ho, D. D. and Yuen, K. Y. 2004. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chem. Biol. 11, 1293-1299.
DOI
ScienceOn
|
19 |
Kathryn, V. H. 2003. SARS-associated coronavirus. N. Engl. J. Med. 348, 1948-1951.
DOI
ScienceOn
|
20 |
Kigawa, T., Yabuki, T., Matsuda, N., Matsuda, T., Nakajima, R., Tanaka, A. and Yokoyama, S. 2004. Preparation of Escherichia coli cell extract for highly productive cell-free protein expression. J. Struct. Funct. Genomics 5, 63-68.
DOI
|
21 |
Krokhin, O., Li, Y., Andonov, A., Feldmann, H., Flick, R., Jones, S., Stroeher, U., Bastien, N., Dasuri, K. V., Cheng, K., Simonsen, J. N., Perreault, H., Wilkins, J., Ens, W., Plummer, F. and Standing, K. G. 2003. Mass spectrometric characterization of proteins from the SARS virus: a preliminary report. Mol. Cell Proteomics 2, 346-356.
|
22 |
Donnelly, C. A., Ghani, A. C., Leung, G. M., Hedley, A. J., Fraser, C., Riley, S., Abu-Raddad, L. J., Ho, L. M., Thach, T. Q., Chau, P., Chan, K. P., Lam, T. H., Tse, L. Y., Tsang, T., Liu, S. H., Kong, J. H., Lau, E. M., Ferguson, N. M. and Anderson, R. M. 2003. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 361, 1761-1766.
DOI
ScienceOn
|
23 |
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R. and Hilgenfeld, R. 2003. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300, 1763-1767.
DOI
|
24 |
Blanchard, J. E., Elowe, N. H., Huitema, C., Fortin, P. D., Cechetto, J. D., Eltis, L. D. and Brown, E. D. 2004. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chem. Biol. 11, 1445-1453.
DOI
ScienceOn
|
25 |
Chou, K. C., Wei, D. Q. and Zhong, W. Z. 2003. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Commun. 308, 148-151.
DOI
ScienceOn
|